Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO)

American Journal of Gastroenterology

Volumn 108, Issue 10, 2013, Pages 1612-1619

  Saad, Wael E A ^a   Wagner, Cynthia ^a   Lippert, Allison ^a   Al Osaimi, Abdullah ^a   Davies, Mark G ^b   Matsumoto, Alan H ^a   Angle, John ^a   Caldwell, Stephen ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; BALLOON OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATIC HYDROTHORAX; HUMAN; HYDROTHORAX; KAPLAN MEIER METHOD; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; ASCITES; BALLOON OCCLUSION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYDROTHORAX; HYPERTENSION, PORTAL; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885474726     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.232     Document Type: Article

References (37)

1. Saxon RR. A new era for transjugular intrahepatic portosystemic shunts? J Vasc Interv Radiol 2004; 15: 217-9
2. Bureau C, Garcia-Pagan JC, Otal P et al. Improved clinical outcome using Polytetrafl uoroethylene-coated syents for TIPS: Results of a randomized study. Gastroenterology 2004; 126: 469-75
3. Angeloni S, Merli M, Salvatori FM et al. Polytetrafl uoroethylene-covered stent graft for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterology 2004; 99: 280-5
4. Rossi P, Salvatori FM, Fanelli F et al. Polytetrafl uoroethylene-covered Nitinol stent-graft for transjugular intrahepatic portosystemic shunt creaton: 3-year experience. Radiology 2004; 231: 820-30
5. Charon J - PM, Alaeddin FH, Pimpalwar SA et al. Results of a retrospective multicenter trial of the Viatorr expended Polytetrafl uoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15: 1219-30
6. Hausegger KA, Karnel F, Georgieva B et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded Polytetrafl uoroethylene- covered stent-graft. J Vasc Interv Radiol 2004; 15: 239-48
7. Vignali C, Bargellini I, Grosso M et al. TIPS wiThexpenaded polytetrafl uoroethylene-covered stent: Results of an Italian multicenter study. Am J Roentegenology 2005; 185: 472-80
8. Rossle M, Siegerstetter V, Euringer W et al. The use of polytetrafl uoroethylene- covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients. A cta Radiol 2 006; 4 7: 6 60-6
9. Montgomery A, Ferral H, Vasan R et al. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) Procedures. Cardiovasc Intervent Radiol 2005; 28: 307-12
10. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: Current status. J Vasc Interv radiol 2005; 16: 449-55
11. Saad WE, Darwish WM, Davies MG et al. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: Clinical outcome. J Vasc Interv Radiol 2010; 21: 218-23
12. Anderson C, Saad WE, Kalagher S et al. Effect of transjugular intrahepatic portosystemic shunt (TIPS) placement on renal function: A 7-year, single center experience. J Vasc Interv Radiol 2010; 21: 1370-6
13. Kanagawa H, Mima S, Kouyama H et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11: 51-8
14. Kiyosue H, Mori H, Matsumoto S et al. Transcatheter oliteration of gastric varices: Part-1: Anatomic classifi cation. Radiographics 2003; 23: 911-20
15. Kiyosue H, Mori H, Matsumoto S et al. Transcatheter oliteration of gastric varices: Part-2: Strategy and techniques based on hemodynamic features. Radiographics 2003; 23: 921-37
16. Kitamoto M, Imamura M, Kamada K et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. Am J Roentgenol 2002; 178: 1167-74
17. Ninoi T, Nishida N, Kaminou T et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: Long-term follow-up in 78 patients. Am J Roentgenol 2005; 184: 1340-6
18. Ninoi T, Nakamura K, Kaminou T et al. TIPS versus transcatheter sclerotherapy for gastric varices. Am J Roentgenol 2004; 183: 369-76
19. Chikamori F, Kuniyoshi N, Shibuya S et al. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy wiThesophageal varices. Hepatogastroenterology 2004; 51: 1379-81
20. Chikamori F, Kuniyoshi N, Shibuya S et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2000; 129: 414-20
21. Cho SK, Shin SW, Lee IH et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: Outcomes and complications in 49 patients. Am J Roentgenol 2007; 189: W365 - 72
22. Miyamoto Y, Oho K, Kumamoto M et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003; 18: 934-42
23. Matsumoto A, Hamamoto N, Nomura T et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol 1999; 94: 643-9
24. Kumamoto M, Toyonaga A, Inoue H et al. Long-term results of balloonoccluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome. J of Gastroenterol Hepatol 2010; 25: 1129-35
25. Chikamori F, Kuniyoshi N, Kawashima T et al. Gastric varices with gastrorenal shunt: Combined therapy using transjugular retrograde obliteration and partial splenic embolization. Am J Roengenol 2008; 191: 555-9
26. Sonomura T, Sato M, Kishi K et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: A feasibility study. Cardiovasc Intervent Radiol 1998; 21: 27-30
27. Park KS, Kim YH, Choi JS et al. Therapeutic effi cacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding. Korean J Gastroenterol 2006; 47: 370-8
28. Shimoda R, Horiuchi K, Hagiwara S et al. Short-term complications of balloon-occluded retrograde transvenous obliteration of gastric varices in patients with portal hypertension: Effects of obliteration of major portosystemic shunts. Abdom Imaging 2005; 30: 306-13
29. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327-36
30. Park SJ, Chung JW, Kim H - C et al. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Intervent Radiol 2010; 21: 503-7
31. Akahoshi T, Hashizume M, Tomikawa M et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: A 10-year experience. Gastroenterology 2008; 23: 1702-9
32. Hirota S, Matsumoto S, Tomita M et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211: 349-56
33. Yamagami T, Kato T, Hirota T et al. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration. Aust Radiol 2007; 51: 334-8
34. Sabri SS, Swee W, Turba UC et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration (BRTO) utilizing sodium TetraDecyl sulfate foam. J Vasc Interv Radiol 2011; 22: 309-16
35. Itkin M, Treratola SO, Stravapoulos SW et al. Portal fl ow and arterioportal shunting after transjugular intrahepatic shunt (TIPS) creation. J Vasc Interv Radiol 2006; 17: 55-62
36. Shioyama Y, Matsueda K, Horihata K et al. Post-TIPS hepatic encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt. Cardiovasc Intervent Radiol 1996; 19: 53-5
37. Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol 2011; 28: 339-49